A Multicenter, Randomized, Placebo-controlled, Double-blind, Dose-finding Phase 2 Clinical Trial to Evaluate the Efficacy in Reduction of Intraocular Pressure and Safety of PHP-201 in Patients With Normal Tension Glaucoma
Phase of Trial: Phase II
Latest Information Update: 28 Oct 2018
At a glance
- Drugs PHP 201 (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- Sponsors pH Pharma
- 02 Jul 2018 Status changed from active, no longer recruiting to completed.
- 04 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 May 2018.
- 04 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 May 2018.